NASDAQ · AIMDW

Ainos, Inc.

$0.12 -$0.01 (-7.37%) 1D Market open
Session Pulse Regular session 1 mentions on Fri No new SEC filings since Mon close its sector ranked 6/11 this week Full pulse →

Key Metrics

$243.66K
Market cap
P/E · TTM
$18.11K
Revenue · TTM
−$13.94M
Net income
EPS · TTM $-4.40
Dividend yield
Free cash flow −$4.38M
Beta · 1Y 1.13
EBITDA · TTM
Gross margin 79.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    Offering paper hit the record (Form 424B5).

    424B5 - Ainos, Inc. (0001014763) (Filer)

    RECEIPT: SEC FORM 424B5, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 26
    The stock moved +108.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 26
  • Apr 30
    The stock moved +111.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 30
  • Apr 27
    From its Feb 2 high, the share price fell 71%.

    Peak close $0.18 on Feb 2; trough close $0.05 on Apr 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -71%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.05 – $0.95
Avg volume · 20D7.5K
Net cash
Book value / share$1.79
IndustryComputer Peripheral Equipment, Nec
ExchangeNASDAQ
About Ainos, Inc.
IPO dateAug 5, 2022
Employees41

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S13.45
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 79.2%
Operating -76,991.8%
Net -76,996.2%
FCF -24,200.8%
ROE / ROIC -131.5% · —

Financial Health

Current ratio0.55
Quick ratio0.50
Debt / equity
Debt / EBITDA
Net cash
Working capital−$2.83M

Cash Flow · TTM

Operating CF −$4.37M
Capex −$9.46K
Free cash flow −$4.38M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

-6.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings